Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
T-allo10 Immunotherapy Results in Enhanced Early Immune Reconstitution and Reduced GvHD with Excellent Clinical Outcomes Post Aß-Depleted HSCT in Pediatric and Young Adult Hematologic Malignancy Patients
À¶Ý®ÊÓÆµ
T-allo10 Immunotherapy Results in Enhanced Early Immune Reconstitution and Reduced GvHD with Excellent Clinical Outcomes Post Aß-Depleted HSCT in Pediatric and Young Adult Hematologic Malignancy Patients Bertaina, A., Bacchetta, R., Cepika, A., Shyr, D. C., Barbarito, G., Oppizzi, L., Chen, P., Saini, G., Lee, J., Kristovich, K., Agarwal, R., Klein, O., Melsop, K., Tate, K., Porteus, M., Roncarolo, M. ELSEVIER. 2024: 3525-3526View details for
View details for